Telephone: +1 (647) 953 9512
Bill Mitoulas, Investor Relations
Forward-Looking Statements
This news release contains forward-looking statements. All statements other than statements of historical fact included in this release are forward-looking statements that involve risks and uncertainties, including statements concerning Company s application for listing on the OTCQB. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the expectations of the Company include the failure of the Company to obtain a listing of its common shares on the OTCQB, regulatory actions and other risks detailed from time to time in the filings made by the Company under securities regulations.
Novamind Announces Symbol Change on OTC Market To NVMDF
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.
Novamind Announces Symbol Change on OTC Market To NVMDF
saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.
Novamind Announces Strategic Investment in Bionomics to Support PTSD Clinical Trial
londonmercury.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from londonmercury.com Daily Mail and Mail on Sunday newspapers.
(2)
Conference highlights industry leaders and innovators in the psychedelic therapy space and features Michael Pollan, author of New York Times bestseller, How to Change Your Mind
TORONTO, ON / ACCESSWIRE / January 29, 2021 / Novamind Inc. (CSE:NM) ( Novamind ), a mental health company specialized in psychedelic medicine, today announced that it will present at Canaccord Genuity s New Paradigms & Treatment Approaches in Mental Health conference on February 3
rd and 4
th, 2021.
The two-day virtual conference will explore the science, intellectual property, and legality of psychedelic compounds, which are at the forefront of breakthrough medical science. Novamind s CEO and Director, Yaron Conforti will present on Wednesday February 3